If hypertension and proteinuria are identified, initiation of an angiotensin converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) is recommended as this has been shown to be renoprotective long term at slowing progression of CKD, especially among those patients with significant proteinuria (19). The gene discussed is ACE; the disease is hypertensive disorder.